Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:700-704
Published online before print August 2, 2004, doi: 10.1161/01.CIR.0000138110.84758.BB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/6/700    most recent
01.CIR.0000138110.84758.BBv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, H.
Right arrow Articles by Duan, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, H.
Right arrow Articles by Duan, D.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Cardiomyopathy
Related Collections
Right arrow Animal models of human disease
Right arrow Ischemic biology - basic studies
Right arrow Ion channels/membrane transport

(Circulation. 2004;110:700-704.)
© 2004 American Heart Association, Inc.


Original Articles

Targeted Inactivation of Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Gene Prevents Ischemic Preconditioning in Isolated Mouse Heart

Hong Chen, MD, PhD*; Luis L. Liu, MD, MSc*; Linda L. Ye, MD; Conor McGuckin, BS; Susan Tamowski, BS; Paul Scowen, BS; Honglin Tian, PhD; Keith Murray, BS; William J. Hatton, PhD; Dayue Duan, MD, PhD

From the Department of Pharmacology and Center of Biomedical Research Excellence, University of Nevada School of Medicine, Reno. Dr. Hong Chen is now at the Department of Pharmacology and Shanghai Institute of Hypertension, Shanghai Second Medical University, Shanghai, China.

Correspondence to Dayue Duan, MD, PhD, FAHA, Associate Professor, Center of Biomedical Research Excellence, Department of Pharmacology, University of Nevada School of Medicine, Manville Medical Building Room 9/MS 318, Reno, NV 89557-0270. E-mail dduan{at}med.unr.edu

Received November 20, 2003; de novo received February 6, 2004; revision received March 10, 2004; accepted March 17, 2004.

Background— Recent evidence suggests that chloride channels may be involved in ischemic preconditioning (IPC). In this study, we tested whether the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channels, which are expressed in the heart and activated by protein kinase A and protein kinase C, are important for IPC in isolated heart preparations from wild-type (WT) and CFTR knockout (CFTR–/–) mice.

Methods and Results— Hearts were isolated from age-matched WT or CFTR–/– (B6.129P2-Cftrtm1Unc and STOCKCftrtm1Unc-TgN 1Jaw) mice and perfused in the Langendorff or working-heart mode. All hearts were allowed to stabilize for 10 minutes before they were subjected to 30 or 45 minutes of global ischemia followed by 40 minutes of reperfusion (control group) or 3 cycles of 5 minutes of ischemia and reperfusion (IPC group) before 30 or 45 minutes of global ischemia and 40 minutes of reperfusion. Hemodynamic indices were recorded to evaluate cardiac functions. Release of creatine phosphate kinase (CPK) in the samples of coronary effluent and infarct size of the ventricles were used to estimate myocardial tissue injury. In WT adult hearts, IPC protected cardiac function during reperfusion and significantly decreased ischemia-induced CPK release and infarct size. A selective CFTR channel blocker, gemfibrozil, abrogated the protective effect of IPC. Furthermore, targeted inactivation of the CFTR gene in 2 different strains of CFTR–/– mice also prevented IPC’s protection of cardiac function and myocardial injury against sustained ischemia.

Conclusions— CFTR Cl channels may serve as novel and crucial mediators in mouse heart IPC.


Key Words: ischemia • myocardial infarction • hemodynamics • ion channels • genes




This article has been cited by other articles:


Home page
J. Physiol.Home page
D. Duan
Phenomics of cardiac chloride channels: the systematic study of chloride channel function in the heart
J. Physiol., May 15, 2009; 587(10): 2163 - 2177.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
X. Fioramonti, S. Contie, Z. Song, V. H. Routh, A. Lorsignol, and L. Penicaud
Characterization of Glucosensing Neuron Subpopulations in the Arcuate Nucleus: Integration in Neuropeptide Y and Pro-Opio Melanocortin Networks?
Diabetes, May 1, 2007; 56(5): 1219 - 1227.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. J. Diaz and G. J. Wilson
Studying ischemic preconditioning in isolated cardiomyocyte models
Cardiovasc Res, May 1, 2006; 70(2): 286 - 296.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S.-Y. Lee and C. O. Lee
Inhibition of Na+-K+ Pump and L-Type Ca2+ Channel by Glibenclamide in Guinea Pig Ventricular Myocytes
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 61 - 68.
[Abstract] [Full Text] [PDF]